CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
71.96
-0.88 (-1.21%)
At close: Jun 26, 2026, 4:00 PM EDT
71.96
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:34 PM EDT
CG Oncology Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for CG Oncology stock have an average target of 91.42, with a low estimate of 80 and a high estimate of 108. The average target predicts an increase of 27.04% from the current stock price of 71.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CG Oncology stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $85 | Buy | Reiterates | $85 | +18.12% | Jun 16, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $83 → $87 | Buy | Maintains | $83 → $87 | +20.90% | May 26, 2026 |
| Wolfe Research | Wolfe Research | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 26, 2026 |
| Wedbush | Wedbush | Buy Reiterates $80 | Buy | Reiterates | $80 | +11.17% | May 18, 2026 |
Financial Forecast
Revenue This Year
11.73M
from 4.04M
Increased by 190.44%
Revenue Next Year
90.41M
from 11.73M
Increased by 670.47%
EPS This Year
-2.66
from -2.08
EPS Next Year
-2.78
from -2.66
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 104.4M | 160.5M | |
| Avg | 11.7M | 90.4M | |
| Low | 1.1M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2,483.9% | 1,268.0% | |
| Avg | 190.4% | 670.5% | |
| Low | -73.2% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.23 | -1.32 | |
| Avg | -2.66 | -2.78 | |
| Low | -3.11 | -3.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.